70 related articles for article (PubMed ID: 11908949)
1. An organic CD4 inhibitor reduces the clinical and pathological symptoms of acute experimental allergic encephalomyelitis.
Edling AE; Choksi S; Huang Z; Korngold R
J Autoimmun; 2002 Mar; 18(2):169-79. PubMed ID: 11908949
[TBL] [Abstract][Full Text] [Related]
2. A CD4-CDR3 peptide analog inhibits both primary and secondary autoreactive CD4+ T cell responses in experimental allergic encephalomyelitis.
Marini JC; Jameson BA; Lublin FD; Korngold R
J Immunol; 1996 Oct; 157(8):3706-15. PubMed ID: 8871674
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitis.
Nicolò C; Sali M; Di Sante G; Geloso MC; Signori E; Penitente R; Uniyal S; Rinaldi M; Ingrosso L; Fazio VM; Chan BM; Delogu G; Ria F
J Immunol; 2010 Jan; 184(1):222-35. PubMed ID: 19949067
[TBL] [Abstract][Full Text] [Related]
4. Characterization of proteolipid protein-peptide-specific CD(4)(+) T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice.
Peng Y; Liu CP
Chin Med J (Engl); 2002 Apr; 115(4):521-4. PubMed ID: 12133288
[TBL] [Abstract][Full Text] [Related]
5. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
6. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
Takács K; Chandler P; Altmann DM
Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
[TBL] [Abstract][Full Text] [Related]
7. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
Mangalam A; Rodriguez M; David C
Eur J Immunol; 2006 Dec; 36(12):3356-70. PubMed ID: 17125142
[TBL] [Abstract][Full Text] [Related]
8. Functional maturation of proteolipid protein(139-151)-specific Th1 cells in the central nervous system in experimental autoimmune encephalomyelitis.
Mohindru M; Kang B; Kim BS
J Neuroimmunol; 2004 Oct; 155(1-2):127-35. PubMed ID: 15342203
[TBL] [Abstract][Full Text] [Related]
9. Prevention of murine EAE by oral hydrolytic enzyme treatment.
Targoni OS; Tary-Lehmann M; Lehmann PV
J Autoimmun; 1999 May; 12(3):191-8. PubMed ID: 10222028
[TBL] [Abstract][Full Text] [Related]
10. Involvement of brain-derived neurotrophic factor (BDNF) in MP4-induced autoimmune encephalomyelitis.
Javeri S; Rodi M; Tary-Lehmann M; Lehmann PV; Addicks K; Kuerten S
Clin Immunol; 2010 Nov; 137(2):181-9. PubMed ID: 20797911
[TBL] [Abstract][Full Text] [Related]
11. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.
Kel J; Oldenampsen J; Luca M; Drijfhout JW; Koning F; Nagelkerken L
Am J Pathol; 2007 Jan; 170(1):272-80. PubMed ID: 17200200
[TBL] [Abstract][Full Text] [Related]
12. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
Chen Y; Inobe J; Weiner HL
J Immunol; 1995 Jul; 155(2):910-6. PubMed ID: 7541826
[TBL] [Abstract][Full Text] [Related]
13. The cytokine signature of MOG-specific CD4 cells in the EAE of C57BL/6 mice.
Hofstetter HH; Karulin AY; Forsthuber TG; Ott PA; Tary-Lehmann M; Lehmann PV
J Neuroimmunol; 2005 Dec; 170(1-2):105-14. PubMed ID: 16257061
[TBL] [Abstract][Full Text] [Related]
14. Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies.
Montero E; Nussbaum G; Kaye JF; Perez R; Lage A; Ben-Nun A; Cohen IR
J Autoimmun; 2004 Aug; 23(1):1-7. PubMed ID: 15236747
[TBL] [Abstract][Full Text] [Related]
15. Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background.
Illés Z; Waldner H; Reddy J; Anderson AC; Sobel RA; Kuchroo VK
Int Immunol; 2007 Oct; 19(10):1235-48. PubMed ID: 17804690
[TBL] [Abstract][Full Text] [Related]
16. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
17. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
18. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.
Tran EH; Hoekstra K; van Rooijen N; Dijkstra CD; Owens T
J Immunol; 1998 Oct; 161(7):3767-75. PubMed ID: 9759903
[TBL] [Abstract][Full Text] [Related]
19. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells.
Kumar V; Coulsell E; Ober B; Hubbard G; Sercarz E; Ward ES
J Immunol; 1997 Nov; 159(10):5150-6. PubMed ID: 9366445
[TBL] [Abstract][Full Text] [Related]
20. An epitope from Acanthamoeba castellanii that cross-react with proteolipid protein 139-151-reactive T cells induces autoimmune encephalomyelitis in SJL mice.
Massilamany C; Steffen D; Reddy J
J Neuroimmunol; 2010 Feb; 219(1-2):17-24. PubMed ID: 20005578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
